WESTFORD, Mass., March 28, 2011 /PRNewswire/ -- Cynosure, Inc.
(Nasdaq: CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
that it will present at the 10th Annual Needham Healthcare
Conference in New York City.
The presentation by President and Chief Executive Officer
Michael Davin and Executive Vice
President, Treasurer and Chief Financial Officer Timothy Baker is scheduled to begin at
2:00 p.m. ET Tuesday, April 5.
To access the live or archived webcast of the event, visit
the "Investor Relations" section of Cynosure's website,
www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems
that are used by physicians and other practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and pigmented lesions, rejuvenate the skin, liquefy
and remove unwanted fat through laser lipolysis and temporarily
reduce the appearance of cellulite. Cynosure's products
include a broad range of laser and other light-based energy
sources, including Alexandrite, pulsed dye, Nd:YAG and diode
lasers, as well as intense pulsed light. Cynosure was founded in
1991. For corporate or product information, contact Cynosure
at 800-886-2966, or visit www.cynosure.com.
Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.